AAAAAA

   
Results: 1-25 | 26-36
Results: 1-25/36
Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. Robert J. Lefkowitz
Authors: Olefsky, JM
Citation: Jm. Olefsky, Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. Robert J. Lefkowitz, MOL ENDOCR, 15(8), 2001, pp. 1456-1457
Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. Robert J. Lefkowitz
Authors: Olefsky, JM
Citation: Jm. Olefsky, Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. Robert J. Lefkowitz, ENDOCR REV, 22(4), 2001, pp. 552-553
Prospects for research in diabetes mellitus
Authors: Olefsky, JM
Citation: Jm. Olefsky, Prospects for research in diabetes mellitus, J AM MED A, 285(5), 2001, pp. 628-632
Synthesis of an organoinsulin molecule that can be activated by antibody catalysis
Authors: Worrall, DS McDunn, JE List, B Reichart, D Hevener, A Gustafson, T Barbas, CF Lerner, RA Olefsky, JM
Citation: Ds. Worrall et al., Synthesis of an organoinsulin molecule that can be activated by antibody catalysis, P NAS US, 98(24), 2001, pp. 13514-13518
Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein
Authors: Huang, J Imamura, T Olefsky, JM
Citation: J. Huang et al., Insulin can regulate GLUT4 internalization by signaling to Rab5 and the motor protein dynein, P NAS US, 98(23), 2001, pp. 13084-13089
Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes
Authors: Ishibashi, K Imamura, T Sharma, PM Huang, J Ugi, S Olefsky, JM
Citation: K. Ishibashi et al., Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes, J CLIN INV, 107(9), 2001, pp. 1193-1202
The Endocrine Society 2001 Annual Awards - Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. RobertJ. Lefkowitz
Authors: Olefsky, JM
Citation: Jm. Olefsky, The Endocrine Society 2001 Annual Awards - Citation for the 2001 Fred Conrad Koch Award of the Endocrine Society to Dr. RobertJ. Lefkowitz, J CLIN END, 86(8), 2001, pp. 4022-4023
beta-arrestin-mediated recruitment of the Src family kinase yes mediates endothelin-1-stimulated glucose transport
Authors: Imamura, T Huang, J Dalle, S Ugi, S Usui, I Luttrell, LM Miller, WE Lefkowitz, RJ Olefsky, JM
Citation: T. Imamura et al., beta-arrestin-mediated recruitment of the Src family kinase yes mediates endothelin-1-stimulated glucose transport, J BIOL CHEM, 276(47), 2001, pp. 43663-43667
Nuclear receptor minireview series
Authors: Olefsky, JM
Citation: Jm. Olefsky, Nuclear receptor minireview series, J BIOL CHEM, 276(40), 2001, pp. 36863-36864
Insulin and insulin-like growth factor I receptors utilize different G protein signaling components
Authors: Dalle, S Ricketts, W Imamura, T Vollenweider, P Olefsky, JM
Citation: S. Dalle et al., Insulin and insulin-like growth factor I receptors utilize different G protein signaling components, J BIOL CHEM, 276(19), 2001, pp. 15688-15695
Insulin signals to prenyltransferases via the Shc branch of intracellular signaling
Authors: Goalstone, ML Leitner, JW Berhanu, P Sharma, PM Olefsky, JM Draznin, B
Citation: Ml. Goalstone et al., Insulin signals to prenyltransferases via the Shc branch of intracellular signaling, J BIOL CHEM, 276(16), 2001, pp. 12805-12812
Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women
Authors: Frias, JP Macaraeg, GB Ofrecio, J Yu, JG Olefsky, JM Kruszynska, YT
Citation: Jp. Frias et al., Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women, DIABETES, 50(6), 2001, pp. 1344-1350
Exercise-stimulated glucose turnover in the rat is impaired by glucosamineinfusion
Authors: Miles, PDG Higo, K Olefsky, JM
Citation: Pdg. Miles et al., Exercise-stimulated glucose turnover in the rat is impaired by glucosamineinfusion, DIABETES, 50(1), 2001, pp. 139-142
PPAR gamma and the treatment of insulin resistance
Authors: Olefsky, JM Saltiel, AR
Citation: Jm. Olefsky et Ar. Saltiel, PPAR gamma and the treatment of insulin resistance, TRENDS ENDO, 11(9), 2000, pp. 362-368
A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1
Authors: Haruta, T Uno, T Kawahara, J Takano, A Egawa, K Sharma, PM Olefsky, JM Kobayashi, M
Citation: T. Haruta et al., A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1, MOL ENDOCR, 14(6), 2000, pp. 783-794
The Diabetes Prevention Program - Baseline characteristics of the randomized cohort
Authors: Bray, GA Culbert, IW Champagne, CM Dawson, L Eberhardt, B Greenway, FL Guillory, FG Hebert, AA Jeffirs, ML Kennedy, BM Lovejoy, JC Melancon, LE Morris, LH Reed, L Perault, J Ryan, DH Sanford, DA Smith, KG Smith, LL St Amant, JA Tucker, E Tulley, RT Vicknair, PC Williamson, D Zachwieja, JJ Tobian, JA Matulik, MJ Clarke, B Collins, DA Czech, KB DeSandre, C Ehrmann, DA Geiger, G Harding-Clay, B Hilbrich, RM McNabb, WL Polonsky, KS Semenske, AR Stepp, KA Watson, PG Mendoza, JT Smith, KA Goldstein, BJ Lark, C Liberoni, R Murphy, L Pepe, C Spandorfer, JM Goldberg, RB Rowe, P Calles, J Casanova, P Donahue, RP Florez, HJ Giannella, A McLymont, V Mendez, J O'Hara, P Ojito, J Prineas, R Haffner, SM Montez, MG Miettinen, H Mobley, CM Mykkanen, LA Rozek, MM Hamman, RF Nash, PV Calonge, BN Hill, JO Hoyer, SR Jortberg, BT Miller-Stone, M Regensteiner, JG Seagle, H Steinke, SC Testaverde, L Van-Dorsten, B Horton, ES Lawton, KE Arky, RA Bryant, M Burke, JP Caballero, E Callaghan, KM Ganda, OP Franklin, T Jackson, SD Jacobsen, AM Kula, LM Kocal, M Malloy, MA Nicosia, M Oldmixon, CF Pan, J Quitingon, M Rubtchinsky, S Seely, EW Schweizer, D Simonson, D Smith, F Solomon, CG Warram, J Kahn, SE Montgomery, BK Fujimoto, WY Knopp, RH Lipkin, EW Marr, M McCann, BS Nguyen, TT Palmer, JP Schwartz, RS Kitabchi, AE Murphy, ME Applegate, WB Bryer-Ash, M Crisler, A Cunningham, G Franklin, AW Frieson, SL Green, DL Imseis, R Kennedy, CL Lambeth, HC Lichtermann, LC Oktaei, H O'Toole, ML Ricks, H Rutledge, LMK Sherman, AR Smith, CM Soberman, JE Williams-Cleaves, BJ Metzger, BE Johnson, MK Behrends, C Cook, ML Fitzgibbon, M Heard, D McPherson, D Molitch, ME Moore, M Pitts, T Roston, S Schinleber, PA Nathan, DM McKitrick, C Abbott, K Anderson, E Bissett, L Cagliero, E Crowell, S Delahanty, L Fritz, S Levina, E Michel, T Norman, D O'Keefe, J Poulos, A Ronan, L Rosal, M Salerno, M Shagensky, C Steiner, B Turgeon, H Young, A Olefsky, JM Carrion-Petersen, ML Barrett-Connor, E Beltran, M Caenepeel-Mills, K Edelman, SV Ford, RO Garcia, J Henry, RR Hill, M Horne, J Leos, D Mudaliar, S Pollard, A Torio-Hurley, J Pi-Sunyer, FX Lee, JE Allison, DB Aronoff, NJ Barreras, IM Crandall, JP Orlando, SJ Parkes, K Rooney, ES Van Wye, GEH Viscovich, KA Marrero, DG Kukman-Kelly, MS Dotson, YF Fineberg, SE Guare, JC Hadden, A Ignaut, JM Jackson, MA Kirkman, MS Porter, BD Prince, MJ Wheeler, ML Ratner, RE Youssef, G Boner, A Bronsord, M Brown, E Cheatham, WW Cola, S Comfort, A Boggs, G Evans, C Levetan, C Kellum, T Nair, AK Passaro, MD Rubin, R Shapiro, S Saad, MF Budgett, M Jinagouda, SD Aziz, A Bernaba, B Bodkin, SL Ciobanu, V Cosenza, C Hagar, JE Khan, A Kumar, D Khawaja, Q Lui, G Marston, AR Mehta, V Sharma, AR Szamos, K Vargas, A Vargas, B Zambrana, N Dagogo-Jack, S Santiago, AS Brendle, JS Fisher, EB Gherardini, DC Heins, JM Marsala, JM Raspberry, CC Santiago, JV Saudek, CD Bradley, VL Brancati, FL Cappelli, S Charleston, JB Rubin, RR Stewart, KJ Sullivan, E Schade, DS Adams, KS Atler, LF Bowling, DA Boyle, PJ Burge, MR Butler, L Canady, JL Chai, L Guillen, M Gutierrez, M Hornbeck, D Johannes, C Katz, P King, C McCalman, R Montoya, DA Rassam, A Senter, W Shamoon, H Brown, JO Adames, J Blanco, E Cox, L Duffy, H Engel, S Friedler, A Harroun, T Howard-Century, CJ Kloiber, S Longchamp, N Pompi, D Walker, EA Wylie-Rosett, J Zonszein, J Wing, RR Kramer, MK Barr, S Clifford, L Culyba, R Frazier, M Gilligan, R Harris, L Harrier, S Henderson, W Jeffries, S Koenning, G Maholic, K Mullen, M Noel, A Orchard, TJ Otto, A Smith, M Stapinski, V Viteri, J Wilson, T Williams, KV Zgibor, J Arakaki, RF Latimer, RW Baker-Ladao, NK Beddow, RM Dias, LM Dupont, DA Fukuhara, LL Mau, MK Odom, SK Perry, RU Tokunaga, JS Knowler, WC Cooeyate, NJ Hoskin, MA Percy, CA Acton, KJ Andre, VL Antone, S Baptisto, NM Barber, R Bennett, PH Benson, MB Bird, EC Broussard, BA Chavez, M Dacawyma, TS Duncan, R Ghahate, JM Glass, M Gohdes, D Grant, G Hanson, RL Horse, E Hughte, G Ingraham, LE Jackson, MC Jay, PA Kaskalla, RS Kessler, D Kobus, KM Morgan, T Nashboo, Y Poirier, S Reidy, M Ridpath, S Roumain, J Rowse, DH Roy, RJ Sangster, S Sewemaenewa, J Wilson, C Yazzie, M Fowler, S Bain, R Bamdad, J Brenneman, T Callaghan, J Edelstein, SL Grimes, KL Jones, S Jones, TL Lachin, JM Mucik, P Orlosky, R Stimpson, CE Suiter, C Temprosa, E Van Aerden, C Eastman, R Garfield, S Andres, R Engelgau, MM Narayan, KMV Williamson, DF Herman, WH Marcovina, SM Aldrich, A Chandler, WL Rautaharju, PM Alexander, T Pemberton, NT Prineas, R Rautaharju, FSR Zhang, Z Mayer-Davis, EJ Martin, M O'Leary, DH Funk, LRC O'Leary, KA Polak, JF Stamm, ER Scherzinger, AL Wing, RR Gillis, BP Kriska, AM Huffmyer, C Venditti, EM Kaplan, RM David, KM Sieber, WJ
Citation: Ga. Bray et al., The Diabetes Prevention Program - Baseline characteristics of the randomized cohort, DIABET CARE, 23(11), 2000, pp. 1619-1629
Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects
Authors: Frias, JP Kruszynska, YT Yu, JG Olefsky, JM
Citation: Jp. Frias et al., Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects, DIABET CARE, 23(1), 2000, pp. 64-69
Diabetes - Gene therapy for rats and mice
Authors: Olefsky, JM
Citation: Jm. Olefsky, Diabetes - Gene therapy for rats and mice, NATURE, 408(6811), 2000, pp. 420-421
Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists
Authors: Olefsky, JM
Citation: Jm. Olefsky, Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists, J CLIN INV, 106(4), 2000, pp. 467-472
Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency
Authors: Miles, PDG Barak, Y He, WM Evans, RM Olefsky, JM
Citation: Pdg. Miles et al., Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency, J CLIN INV, 105(3), 2000, pp. 287-292
The osmotic shock-induced glucose transport pathway in 3T3-L1 adipocytes is mediated by Gab-1 and requires Gab-1 associated phosphatidylinositol 3-kinase activity for full activation
Authors: Janez, A Worrall, DS Imamura, T Sharma, PM Olefsky, JM
Citation: A. Janez et al., The osmotic shock-induced glucose transport pathway in 3T3-L1 adipocytes is mediated by Gab-1 and requires Gab-1 associated phosphatidylinositol 3-kinase activity for full activation, J BIOL CHEM, 275(35), 2000, pp. 26870-26876
The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1adipocytes
Authors: Nakashima, N Sharma, PM Imamura, T Bookstein, R Olefsky, JM
Citation: N. Nakashima et al., The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1adipocytes, J BIOL CHEM, 275(17), 2000, pp. 12889-12895
Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes
Authors: Egawa, K Nakashima, N Sharma, PM Maegawa, H Nagai, Y Kashiwagi, A Kikkawa, R Olefsky, JM
Citation: K. Egawa et al., Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes, ENDOCRINOL, 141(6), 2000, pp. 1930-1935
The acute and chronic stimulatory effects of endothelin-1 on glucose transport are mediated by distinct pathways in 3T3-L1 adipocytes
Authors: Ishibashi, KI Imamura, T Sharma, PM Ugi, S Olefsky, JM
Citation: Ki. Ishibashi et al., The acute and chronic stimulatory effects of endothelin-1 on glucose transport are mediated by distinct pathways in 3T3-L1 adipocytes, ENDOCRINOL, 141(12), 2000, pp. 4623-4628
Insulin-mediated cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes
Authors: Janez, A Worrall, DS Olefsky, JM
Citation: A. Janez et al., Insulin-mediated cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes, ENDOCRINOL, 141(12), 2000, pp. 4657-4663
Risultati: 1-25 | 26-36